NCT06132243View on ClinicalTrials.gov

Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2023

Conditions

Myelofibrosis

Interventions

DRUG

Jaktinib Hydrochloride Tablets

Orally, one tablet at a time

Trial Locations (1)

410011

The Third Hospital of Changsha, Changsha

All Listed Sponsors

lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT06132243 - Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions | Biotech Hunter | Biotech Hunter